We developed a conceptual framework exploring pathways between trade and investment
and noncommunicable disease (NCD) outcomes. Despite increased knowledge of the …

Lexchin cites that the pharmaceutical industry has remained near or at the top of the list for
profitability for many decades. The myth is that its profits come from producing and selling …

The Trans-Pacific Partnership Agreement (TPPA) is a regional trade agreement being
negotiated by 12 countries, including New Zealand and the United States of America (USA) …

In an era where legally binding international trade agreements are increasingly shaping
domestic regulation in a wide range of areas, the Trans-Pacific Partnership Agreement …

Litigated pharmaceutical patents are a valuable source of data on how much inventiveness
is required for a patent grant and what are the costs of patents. Although innovation is …

Although officially dead due to US withdrawal from agreement, the Trans-Pacific Partnership
agreement (TPP) is now in a 'zombie'state being resurrected in different ways by most of its …

ABSTRACT In the Trans Pacific Partnership (TPP) Agreement negotiations, the USA
successfully pursued intellectual property (IP) provisions that will affect the affordability of …

Most free trade agreements (FTAs) signed by the United States, the European Union and the
members of the European Free Trade Association (EFTA) in the last 15 years contain …

This article aims to discuss the main consequences of the implementation of the Trans-
Pacific Partnership Agreement (TTPA) in the pharmaceutical sector in regard to public …

Free Trade Agreement (FTA) is an agreement which being argued as to bring many
economic benefits to signatory countries. FTA generally aims at removing trade barriers and …